PMID: 19015485

Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.

Sevigny J J, Ryan J M, van Dyck C H, Peng Y, Lines C R, Nessly M L, MK-677 Protocol 30 Study Group

Neurology · 2008

Vol. 71, Issue 21, pp. 1702-8

View on PubMedDOI

This entry links to third-party literature. For research use only.

Activities of Daily LivingAgedAged, 80 and overAlzheimer DiseaseAntipsychotic AgentsConfidence IntervalsDisease ProgressionDouble-Blind MethodFemaleHumans

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.